NASDAQ: BTAI       Bioxcel Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
28.05   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):108,950
4 Weeks Range:30.20 - 31.42
4 Weeks Price Volatility (%):
52 Weeks Range:23.07 - 67.74
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, which is a sublingual thin film formulation of dexmedetomidine designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. The company's other product candidates are BXCL502 and BXCL702 which is focused on neurodegeneration and hematological malignancies.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1768  2482  333  6869 

Top 10 Active Counters
 TLGT 0.174-0.028 
 AVIR 14.279-26.321 
 AAPL 148.21+1.66 
 COG 22.25+0.49 
 NIO 40.09+0.48 
 AMC 43.271+0.241 
 CLDR 15.99+0.01 
 SNR 8.92-8.92 
 CCL 22.66-0.47 
 AMD 115.308-1.122